Design, Synthesis, Characterization, Molecular Docking Studies, In vitro and In vivo Cervical Cancer Activity of Novel N-Substituted Pyrazole Derivatives

Sudha, T. and Mahalakshmi, D. and Nallasivan, P. Kumar (2024) Design, Synthesis, Characterization, Molecular Docking Studies, In vitro and In vivo Cervical Cancer Activity of Novel N-Substituted Pyrazole Derivatives. Asian Journal of Chemistry, 36 (10). pp. 2260-2268. ISSN 0970-7077

[thumbnail of 005-32021+(2260-2268).pdf] Text
005-32021+(2260-2268).pdf

Download (1MB)

Abstract

Design, Synthesis, Characterization, Molecular Docking Studies, In vitro and In vivo Cervical Cancer Activity of Novel N-Substituted Pyrazole Derivatives T. Sudha https://orcid.org/0000-0001-8821-3999 D. Mahalakshmi https://orcid.org/0000-0002-2394-7366 P. Kumar Nallasivan https://orcid.org/0000-0001-8918-6769

The aim of this study is to design, synthesize, characterize few novel N-substituted pyrazole derivatives and evaluated for their anticancer capabilities; these compounds were selected based on their ability to inhibit the HPV E6 protein. The IR, 1H & 13C NMR, mass spectral and elemental analysis were used to determine the structural details of the newly synthesized substances. The molecular docking was performed using Auto Dock Vina, and the protein-ligand interaction was analyzed using Discovery Studio. The sulforhodamine B (SRB) assay was used to determine the in vitro anticancer activity against the HeLa cell line. Body weight analysis, mean survival time and % increase in life span approaches were used to assess in vivo anticancer effectiveness in Swiss albino mice bearing Dalton’s Lymphoma Ascites (DAL) tumor model. Synthesized compounds have excellent docking energies, according to docking experiments. Compounds I, II and III were selected for anticancer activity in vivo DAL-bearing mice based on the findings of their in vitro and SRB assays exhibiting the antiproliferative activity. Pyrazole derivatives, compounds I and III, demonstrated significant potential as anticancer agents.
09 30 2024 2260 2268 https://creativecommons.org/licenses/by/4.0 10.14233/ajchem.2024.32021 https://asianpubs.org/index.php/ajchem/article/view/36_10_5 https://asianpubs.org/index.php/ajchem/article/download/36_10_5/29824 https://asianpubs.org/index.php/ajchem/article/download/36_10_5/29824

Item Type: Article
Subjects: Pharmaceutical Chemistry and Analysis > Pharmaceutical Additives Analysis
Domains: Pharmaceutical Chemistry and Analysis
Depositing User: Mr IR Admin
Date Deposited: 23 Aug 2025 08:50
Last Modified: 23 Aug 2025 08:50
URI: https://ir.vistas.ac.in/id/eprint/10389

Actions (login required)

View Item
View Item